Documentation Centre

 

 

  of 1026 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Redefining metabolically healthy obesity. Nat Rev Endocrinol. 2018.doi: 10 November 15, 2018 Redefining metabolically healthy obesity. Nat Rev Endocrinol. 2018.doi: 10 Greenhill C Key Publications
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714-724 November 14, 2018 Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714-724 Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB Key Publications
Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur Heart J. 2018;39:2497-2505 November 13, 2018 Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease. Eur Heart J. 2018;39:2497-2505 Mirtschink P, Jang C, Arany Z, Krek W Key Publications
Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72:330-343 November 12, 2018 Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72:330-343 Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE Key Publications
Refining lipoprotein(a) associated cardiovascular risk in women. J Am Coll Cardiol. 2018;72:297-299 November 09, 2018 Refining lipoprotein(a) associated cardiovascular risk in women. J Am Coll Cardiol. 2018;72:297-299 Rosenson RS, Marcovina SM Key Publications
Lipoprotein(a) and cardiovascular risk prediction among women. J Am Coll Cardiol. 2018;72:287-296 November 08, 2018 Lipoprotein(a) and cardiovascular risk prediction among women. J Am Coll Cardiol. 2018;72:287-296 Cook NR, Mora S, Ridker PM Key Publications
Low-grade inflammation modifies cardiovascular risk even at very low LDL-C levels: Are we aiming for a dual target concept? Circulation. 2018;138:150-153 November 07, 2018 Low-grade inflammation modifies cardiovascular risk even at very low LDL-C levels: Are we aiming for a dual target concept? Circulation. 2018;138:150-153 Koenig W Key Publications
Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138:141-149 November 06, 2018 Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138:141-149 Pradhan AD, Aday AW, Rose LM, Ridker PM Key Publications
Inflammatory and cholesterol risk in the FOURIER trial. Circulation. 2018;138:131-140 November 06, 2018 Inflammatory and cholesterol risk in the FOURIER trial. Circulation. 2018;138:131-140 Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, Lira Pineda A, Honarpour N, Wang H, Murphy SA, Keech A, Pedersen TR, Sabatine MS Key Publications
Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. BMJ. 2018;362:k2575 November 02, 2018 Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study. BMJ. 2018;362:k2575 Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Willett WC, Giovannucci EL Key Publications

  of 1026 Next page

Go to page: of